Over 55% of people suffer from swallowing difficulties when taking tablets and/or capsules, according to a recent market study commissioned by HERMES PHARMA. It surveyed 2,000 people in the US and Germany and was conducted by market research expert Spiegel Institut Mannheim. The findings also pointed out that swallowing difficulties are likely to have a negative impact on compliance and identified the weaknesses of conventional tablets and capsules in comparison to alternative solid dosage forms…
Read the full version of the article published in EPM magazine, October 2014